At PathoQuest, we understand that you need to develop your innovative biologics safely and timely in a complex testing environment. PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing for global biopharmaceutical and emerging biologics companies.
With a proven track record in the provision of regulated contract research services, PathoQuest offers a team of 50 genomic experts based in France and the U.S. Our expert CRO team are readily available to support with rapid and robust quality controlled (QC) testing at GMP and non-GMP level.
Let’s work together to transform the future of biologic therapies and treatments to transform patient lives.